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Abstract
Background: Ashbya gossypii naturally overproduces riboflavin and has been utilized for industrial riboflavin
production. To improve riboflavin production, various approaches have been developed. In this study, to investigate
the change in metabolism of a riboflavin-overproducing mutant, namely, the W122032 strain (MT strain) that was
isolated by disparity mutagenesis, genomic analysis was carried out.
Results: In the genomic analysis, 33 homozygous and 1377 heterozygous mutations in the coding sequences of
the genome of MT strain were detected. Among these heterozygous mutations, the proportion of mutated reads in
each gene was different, ranging from 21 to 75%. These results suggest that the MT strain may contain multiple
nuclei containing different mutations. We tried to isolate haploid spores from the MT strain to prove its ploidy, but
this strain did not sporulate under the conditions tested. Heterozygous mutations detected in genes which are
important for sporulation likely contribute to the sporulation deficiency of the MT strain. Homozygous and
heterozygous mutations were found in genes encoding enzymes involved in amino acid metabolism, the TCA
cycle, purine and pyrimidine nucleotide metabolism and the DNA mismatch repair system. One homozygous
mutation in AgILV2 gene encoding acetohydroxyacid synthase, which is also a flavoprotein in mitochondria, was
found. Gene ontology (GO) enrichment analysis showed heterozygous mutations in all 22 DNA helicase genes and
genes involved in oxidation-reduction process.
Conclusion: This study suggests that oxidative stress and the aging of cells were involved in the riboflavin over-
production in A. gossypii riboflavin over-producing mutant and provides new insights into riboflavin production in A.
gossypii and the usefulness of disparity mutagenesis for the creation of new types of mutants for metabolic engineering.
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Background
Ashbya gossypii, a filamentous fungus, is a riboflavin
producer and has been utilized for industrial riboflavin
production. Therefore, many studies on the metabolic
mechanism of riboflavin production in A. gossypii have
been carried out, and several overproducing mutants
have been isolated [1]. In addition, the genome of A. gos-
sypii is very similar to that of Saccharomyces cerevisiae,
which is a budding yeast, and 91% of 4476 annotated A.
gossypii genes are syntenic to those of S. cerevisiae [2].
This finding provides for many researchers to identify
differences between the growth of filamentous fungi and
budding yeasts [3].
Isocitrate lyase (ICL), which catalyzes the cleavage re-
action of isocitrate to succinate and glyoxylate, is an im-
portant enzyme for riboflavin production in A. gossypii
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: park.enoch@shizuoka.ac.jp
1Green Chemistry Research Division, Research Institute of Green Science and
Technology, Shizuoka University, Ohya 836, Suruga-ku, Shizuoka, Japan
2Department of Agriculture, Graduate School of Integrated Science and
Technology, Shizuoka University, Ohya 836, Suruga-ku, Shizuoka, Japan
Full list of author information is available at the end of the article
Kato et al. BMC Genomics          (2020) 21:319 
https://doi.org/10.1186/s12864-020-6709-7
[4]. The mutant isolated using itaconate, which is an
ICL inhibitor, produced a 25-fold higher level of ribofla-
vin in soybean oil-containing medium than the wild
type. The mutant isolated on oxalate-containing medium
showed a 5-fold higher riboflavin yield than wild type in
rapeseed oil medium [5]. In addition, genetic engineering
of this fungus has been utilized for riboflavin production
[6]. Overexpression of riboflavin biosynthetic genes in A.
gossypii contributed to the enhancement of riboflavin
production [7]. Disruption of cytoplasmic serine hydroxy-
methyltransferase gene (AgSHM2) in A. gossypii also im-
proved riboflavin production 10-fold compared to the wild
type [8]. Reinforcement of the purine biosynthetic pathway
in A. gossypii also improved riboflavin production [9, 10].
These results show that glycine and the purine biosynthetic
pathway are important factors for riboflavin production in
A. gossypii. Along with genetic engineering, metabolic in-
vestigation using a 13C tracer has been carried out to im-
prove riboflavin production in A. gossypii [11, 12].
Recently, the A. gossypii w122032 mutant (MT strain),
which is an overproducer of riboflavin, was isolated by
the disparity mutagenesis method [13]. This disparity
mutagenesis was first demonstrated by Furusawa et al.,
and disparity theory has been developed by computer
simulation [14, 15]. Expression of error-prone DNA
polymerase δ in hosts generates increased diversity of
hosts that have mutated genomes and leads to the isola-
tion of mutant strains with desired properties. In the
MT strain, mutation sites in metabolic pathways were
suggested by DNA microarray analysis, proteome ana-
lysis and metabolic flux analysis [13, 16]. However, def-
inite mutation sites have not been identified to date.
In this study, using a next-generation DNA sequencer,
genome analysis of the MT strain was carried out, and
mutation sites in the genome of this mutant compared
to that of wild type were determined to clarify the mech-
anism of the riboflavin over-production in MT strain
considering the previous analyses of MT strain [13, 16].
In addition, we discussed the roles of genes mutated in
the MT strain.
Results and discussion
Genome analysis of each strain and identification of
mutations in the genome sequence of MT
We previously reported that the riboflavin over-
producing mutant (MT strain) was isolated by disparity
mutagenesis in the presence of H2O2, itaconate and ox-
alate and phenotypes of this MT strain were character-
ized by transcriptomic, proteomic and metabolic flux
analyses [13, 16]. In this study, to reveal the genotype of
MT strain, genome resequencing and single-nucleotide
polymorphisms (SNP) analysis were carried out. Whole-
genome shotgun sequencing for WT and MT generated
1,083,909 and 1,519,777 high-quality read pairs totaling
approximately 593 and 836Mb, respectively. The high-
quality reads of WT and MT were aligned to the reference
genome of A. gossypii ATCC10895, resulting in sequence
coverages of 41.9–43.4 and 46.7–53.6, respectively, for
chromosome I–VII. Among the variants identified by the
Genome Analysis Toolkit (GATK) based on the aligned
reads for WT and MT, mutations in open reading frames
(ORFs), missense mutations, frameshift mutations and
nonsense mutations were analyzed. In WT, which is same
as the original strain A. gossypii ATCC10895, amino acid
sequences encoded by all ORFs were the same as those of
strain ATCC10895, except for the SEN2 gene (AGOS_
AGR073C), which encodes a subunit of the tRNA splicing
endonuclease in S. cerevisiae (Supplementary material
Table S1). This result indicates that this WT, which has
been maintained in our laboratory, could have gained this
heterozygous mutation. However, this WT was used in
this study because this gene may not be involved in ribo-
flavin production, given the function of the gene product.
Additionally, some silent mutations were also detected
(data not shown).
From the single-nucleotide variant (SNV) analysis be-
tween the genome sequences of WT and MT, we de-
tected 33 homozygous and 1377 heterozygous mutations
in the coding sequences of the genome of MT strain
(Supplementary materials Tables S1 and S2), which
cause missense, nonsense and frameshift mutations, in
addition to silent mutations. These heterozygous muta-
tions suggest that nuclei of the MT strain are polyploid.
In the 1377 heterozygous mutations, the proportion of
mutations in each gene was different. The highest pro-
portion was 75% (chromosome VI:799,900 in AgOCT1,
AGOS_AFR198W), and the lowest proportion was 21%
(chromosome VII:198,537 and 198541 in AgATP1,
AGOS_AGL272C) (Fig. 1). Most heterozygous mutants
were found to have ratios of 40–60%. These results sug-
gest that the MT strain may contain multiple nuclei con-
taining different mutations. To prove its ploidy, we tried
to isolate haploid spores from the MT strain, but this
strain did not produce spores under the conditions
tested. This result indicates that the MT strain lost the
ability to sporulate even though it was previously re-
ported that the riboflavin production in A. gossypii is re-
lated with its spore production [17]. A. gossypii is a
naturally multinucleate fungus, but this fungus may be
haploid, and the spores of this fungus produced by asex-
ual sporulation are also haploid [2, 18]. However, Ander-
son et al. reported that ploidy variation was observed in
A. gossypii with minor aneuploidy [19]. In this study, the
proportion of heterozygous mutations in each gene
ranged from 75 to 21%, and most heterozygous muta-
tions were found at 40–60%. This result may be caused
by the polyploidy or multinucleate cells of this organism.
Anderson et al. [19] also discussed the low germination
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frequency of spores produced from variable polypoid nu-
clei. Two possibilities were suggested: a reduction in
ploidy to uninucleate haploid spores and the formation
of spores with variable ploidy. In this study, the MT
strain never produced haploid spores.
Which corresponds, interestingly, we found a region
representing ~ 2-fold sequence coverage compared to
other regions in chromosome VII of the MT strain, which
correspond to the rRNA gene repeats (Chr VII:441,317-
762,344) (Fig. 2). In yeasts, the number of rRNA gene
repeats is normally maintained for genome stability and
determination of life span [20, 21]. Moreover, the rRNA
gene controls chromosome homeostasis [22]. When the
number of rRNA gene repeats increases, rRNA gene in-
stability and aging phenotypes are observed. Silva et al.
showed that the riboflavin-overproducing Ashbya mutants
are vulnerable to photoinduced oxidative DNA damage
and accumulate reactive oxygen species (ROS) [23]. The
ROS is largely involved in the aging of cells, suggesting
that the riboflavin production in A. gossypii may be associ-
ated with the aging of cells.
It is reasonable that homozygous mutations have more
crucial effects on riboflavin production in the MT strain
compared to heterozygous mutations. We selected candi-
date mutations among 33 homozygous mutations in the
coding sequence of the genome of MT strain, as shown in
Table 1. Among the 33 homozygous mutations, the SEN2
gene (AGOS_AGR073C) has one homozygous mutation
in the MT strain, in contrast to the WT strain used in this
study, which has one heterozygous mutation at the same
nucleotide. Four homozygous mutations in the amino acid
metabolism of A. gossypii were detected.
Fig. 1 Proportion of mutated reads in each gene among 1377 heterozygous mutations in the coding sequences of the MT genome. The highest
proportion was 75% (OCT1, AGOS_AFR198W), and the lowest proportion was 21% (AGOS_AGL272C). Most heterozygous mutations were
detected at 40–60%
Fig. 2 Sequence coverage line graph of chromosomes in MT strain and WT strain. Compared to the WT strain, a large number of rRNA gene
repeat sequences in chromosome VII were detected in the MT strain
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First, a frameshift mutation in the AgSHM2 gene
(AGOS_ACR215C) was detected in the genome of the
MT strain. This gene encodes serine hydroxymethyl-
transferase 2 (SHMT), and it was previously reported
that disruption of this gene enhanced the productivity of
riboflavin in A. gossypii, although the growth of the or-
ganism was compromised [7]. The frameshift mutation
causes the deletion of 25 amino acid residues at the C-
terminus of AgSHM2 and the addition of 6 extra amino
acid residues in the deletion mutant. This C-terminal re-
gion may not be directly involved in catalytic activity
[24]. However, the L474F mutation in this region of hu-
man and rabbit SHMT causes a decrease in the binding
of this protein to co-factors [25]. Therefore, this frame-
shift mutation in the MT strain may lead to a decrease
in the SHMT activity of AgSHM2. In addition to the
homozygous frameshift mutation, one heterozygous mu-
tation (593G→A), which causes a missense mutation,
R198Q, was also detected in the AgSHM2 gene.
Second, a missense mutation (206C→T) in the AgARO2
gene (AGOS_ADL287C), which produces the T69M mu-
tant, was detected. In S. cerevisiae, this gene encodes choris-
mate synthase, which produces chorismate, a building block
of aromatic compounds. Because T69 in the chorismate syn-
thase of S. cerevisiae is distant from the catalytic site, this
residue may not be directly involved in catalytic activity [26].
In addition, this enzyme also exhibits flavin reductase activ-
ity for the synthesis of reduced flavin mononucleotide
(FMN), which is required for chorismate synthase activity.
Third, a missense mutation (1365G→T) in the AgILV2
gene (AGOS_AEL305C), which produces the Q455H mu-
tant, was detected. In S. cerevisiae, this gene encodes the
large subunit of acetohydroxyacid synthase (AHAS),
which solely catalyzes the synthesis of 2-acetolactate and
2-aceto-2-hydroxybutyrate. This reaction is the first step
of branched-chain amino acid biosynthesis. This mutation
may not have considerable effects on enzymatic activity
because Q455 is not in the co-factor-binding sites [27].
This enzyme requires flavin adenine dinucleotide (FAD)
as a co-factor, even though this reaction does not require
oxidation and reduction. A small subunit of AHAS
encoded by the ScILV6 gene regulates the AHAS activity
of ScILV2 in yeast [28]. A. gossypii also has AgILV2 and
AgILV6 genes. In AgILV6 genes, three heterozygous mis-
sense mutations (140G→A, S47N; 155G→A, S52N;
673G→T, G225C) were detected.
Fourth, a missense mutation (365G→A) in the
AgLYS5 gene (AGOS_AGR382W), which produces the
R122H mutant, was detected. In S. cerevisiae, ScLYS5
(4′-phosphopantetheinyl transferase, PPTase) converts
the apo-form of ScLYS2 (α-aminoadipate reductase) to
the active holo-form by the transfer of phosphopan-
tetheine and is present in the lysine biosynthetic path-
way [29]. In addition to modification, PPTase is involved
in fungal growth, the biosynthesis of secondary metabo-
lites and asexual and sexual development [30, 31].
In pyrimidine metabolism in A. gossypii, one homozy-
gous mutation was detected in the AgCDD1 gene



















III 726,948 CG C 1167.38 frameshift AGOS_ACR215C Cytosolic serine
hydroxymethyltransferase
(AgSHM2)
c.1332delC p.Q445fs 0 30
IV 1,433,
004
T A 1442.42 missense AGOS_ADR404C Oleate-activated transcription
factor (AgOAF1 or AgPIP2)
c.2317A > T p.T773S 0 38
IV 1,433,
040
T G 1455.42 missense AGOS_ADR404C Oleate-activated transcription




IV 199,365 G A 1523.42 missense AGOS_ADL287C Chorismate synthase (AgARO2)a c.206C > T p.T69M 0 39
V 70,024 C A 1836.42 missense AGOS_AEL305C Large subunit of
acetohydroxyacid synthase
(AgILV2)a
c.1365G > T p.Q455H 0 46
VII 791,717 C A 1505.42 missense AGOS_
AGL123W
Cytidine deaminase (AgCDD1) c.314C > A p.P105Q 0 41
VII 962,069 G A 1560.42 nonsense AGOS_AGL036C Heat shock protein 104 (AgHSP104) c.1066C > T p.Q356* 0 42
VI 1,753,
850





c.365G > A p.R122H 0 49
These homozygous mutations are a subset among all 32 homozygous mutations which are shown in Table S1
aFlavoproteins
*Translation stops here
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(AGOS_AGL123W), which encodes cytosine deaminase
in S. cerevisiae. This enzyme catalyzes the conversion of
cytidine to uridine in the pyrimidine salvage pathway in
S. cerevisiae [32]. In A. gossypii, in the pyrimidine salvage
pathway, uracil phosphoribosyltransfrase, encoded by
the AgFUR1 gene, controls the amount of phosphoribo-
syl pyrophosphate (PRPP), which is one of the precur-
sors of riboflavin in this organism [33].
Regarding the riboflavin production in A. gossypii, one
missense homozygous mutation (1180G→A) was de-
tected in AgSOK2 gene (AGOS_ABR055C) of MT strain.
AgSOK2 is one of fungal-specific group of transcription
factors and involved in the sporulation and riboflavin
production in A. gossypii [34]. Deletion of AgSOK2 gene
led to the strong reduction of the riboflavin production
and the deficiency of the sporulation by the downregula-
tion of AgIME2 and AgNDT80 gene. In MT strain, the
riboflavin overproduction and the sporulation deficiency
were observed even though AgSOK2 gene had one
homozygous mutation. Therefore, it is possible that the
riboflavin production and the sporulation in A. gossypii
may be regulated differently by AgSOK2 or the homozy-
gous mutation in AgSOK2 gene may cause the sporulation
deficiency but may not cause the reduction of riboflavin
production.
Two homozygous mutation (2317A→T and 2281A→
C) in AgOAF1 gene (AGOS_ADR404C) were also found
in the genome of MT strain. In the conventional medium
previously reported (initial rapeseed oil concentration 100
g/L) [13], WT and MT strains consumed 78.6 and 62.7 g/
L of rapeseed oil for 144 and 168 h cultivation in a 3 L jar-
fermentor, respectively (unpublished data). Riboflavin pro-
duction in WT and MT strains during the cultivation was
1.52 and 6.49 g/L, respectively. This result corresponded
to the data in this study showing two homozygous muta-
tions in AgOAF1 gene (AGOS_ADR404C) encoding a
subunit of an oleate-activated transcription factor which
binds to the oleate response element in promoters of
oleate-responsive genes. A. gossypii has more two genes
encoding homologs of ScOAF1 gene (AGOS_ADR403C
and AGOS_ADR405C). AGOS_ADR403C and AGOS_
ADR405C also had one and two heterozygous mutations,
respectively (Supplementary material Table S2).
In the MT strain, 1377 heterozygous mutations in the
coding sequences were also detected (Supplementary ma-
terial Table S2). Heterozygous mutations usually lead to
less critical effects than homozygous mutations [35, 36].
However, heterozygous mutations sometimes have negative
effects on protein functions as well as haploinsufficiency
[37, 38]. In addition, some mutated proteins that form mul-
timers exhibit dominant-negative effects on functions [39,
40]. Therefore, it is possible that heterozygous mutations
also have some effect on riboflavin production in the MT
strain. Among the 1377 heterozygous mutations in the
coding sequences, unusual heterozygous mutations were
detected (Table 2). Most genes in the TCA cycle have het-
erozygous mutations. In particular, three genes, namely,
AgSDH1 (AGOS_ACR052W), AgSDH2 (AGOS_ACL065C),
and AgSDH3 (AGOS_AFR207C), encoding subunits of suc-
cinate dehydrogenase in S. cerevisiae, have heterozygous
mutations. In addition, several genes encoding flavoproteins
in the mitochondria also have heterozygous mutations.
AgSDH1 is also a flavoprotein. Flavoproteins in mitochon-
dria of yeasts function in redox processes via the
transfer of electrons [41]. In addition, the flavin in fla-
voproteins participates in the reduction of heme iron
or iron-sulfur clusters. In this study, we detected sev-
eral homozygous mutations (AgARO2, AgILV2) and
heterozygous mutations {AgSDH1, AgPDX1 (AGOS_
AGR323C), AgNDI1 (AGOS_AFR447C), AgDLD1 (AGOS_
AER321W), AgCBR1 (AGOS_ADL087W), AgGLR1
(AGOS_AGR196W), AgMTO1 (AGOS_AGR196W),
AgMET5 (AGOS_ABL077W), AgPUT1 (AGOS_
AGL165W), AgFAS1 (AGOS_AER085C), AgHEM14
(AGOS_AAR021W), AgERV2 (AGOS_ACR175W), and
AgERO1 (AGOS_ADL348W)} in genes encoding flavopro-
teins in S. cerevisiae. It is possible that the riboflavin over-
production in the MT strain is associated with these
mutations of genes encoding flavoproteins and dysfunction
of the TCA cycle. MT strain is hypothesized to have mito-
chondrial dysfunction because most genes in the TCA cycle
and genes encoding flavoproteins have heterozygous muta-
tions. One homozygous mutation in AgILV2 gene which en-
codes a flavoprotein, AHAS, localized in mitochondria, was
also found (Tables 2 and 3). In humans, riboflavin supple-
mentation rescues the mitochondrial disorders associated
with the deficiencies of some flavoproteins and respiratory
chains [42]. Additionally, we previously reported that the ex-
pression of genes involved in TCA cycles in MT strain was
decreased compared to WT strain. Also the MT strain
shown the decreased succinate and increased lactate and
pyruvate compared to WT strain [13, 16]. These previous
results also suggest the overproduction of riboflavin in the
MT strain may also be associated with mitochondrial
dysfunction.
Related to the heterozygous mutations in flavoprotein
genes, a heterozygous mutation in the AgFMN1 gene
(AGOS_ABL109W) was detected (Table 2). In S. cerevi-
siae, this gene encodes riboflavin kinase, which catalyzes
the synthesis of FMN from riboflavin. FMN is converted
to FAD by FAD synthase. The downregulation of
AgFMN1 gene expression prevented riboflavin consump-
tion in this fungus, and the ribC-deleted mutant deregu-
lated riboflavin production in B. subtilis by preventing
FMN and FAD accumulation [43, 44]. Therefore, this
mutation may partially contribute to riboflavin overpro-
duction in the MT strain by partial restriction of the
riboflavin flow to FMN. Additionally, heterozygous
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III 456,890 C T 327.19 missense AGOS_
ACR056W
Phosphoglycerate mutase (AgGPM1) c.374C > T p.A125V 28 12 0.300
IV 287,997 T C 503.19 missense AGOS_
ADL237C
6-phosphofructo-2-kinase (AgPFK26) c.1796A >
G
p.D599G 24 18 0.429
IV 1,362,
124
A T 725.19 missense AGOS_
ADR368W
Pyruvate kinase (AgPYK1) c.1040A > T p.K347M 21 23 0.523
V 242,262 A C 708.19 missense AGOS_
AEL208W
Alpha subunit of phosphofructokinase
(AgPFK1)
c.2255A > C p.K752T 27 23 0.460
V 426,255 C T 700.19 missense AGOS_
AEL106W
Fructose-2,6-bisphosphatase (AgFBP26) c.103C > T p.R35W 21 23 0.523
VI 96,950 A C 1088.19 missense AGOS_
AFL185W
Beta subunit of phosphofructokinase
(AgPFK2)
c.1963A > C p.N655H 35 37 0.514
VI 97,509 AT A 907.15 frameshift AGOS_
AFL185W
Beta subunit of phosphofructokinase
(AgPFK2)
c.2526Tdel p.Phe842fs 20 32 0.615
TCA cycle
I 346,384 G A 758.19 missense AGOS_
AAR004C
Citrate synthase (AgCIT1) c.68C > T p.T23M 18 25 0.581
I 634,291 G T 991.19 Nonsense AGOS_
AAR162C
Pyruvate carboxylase (AgPYC2) c.3266c > A p.S1089* 31 33 0.514
I 634,669 A T 836.19 missense AGOS_
AAR162C
Pyruvate carboxylase (AgPYC2) c.2888 T >
A
p.L963Q 21 26 0.553
III 238,489 T G 729.19 missense AGOS_
ACL065C
Iron-sulfur protein subunit of succinate
dehydrogenase (AgSDH2)
c.697A > C p.T233P 25 23 0.479
III 238,962 G A 1051.19 missense AGOS_
ACL065C
Iron-sulfur protein subunit of succinate
dehydrogenase (AgSDH2)
c.224C > T p.T75M 20 32 0.615
III 451,903 G A 879.19 missense AGOS_
ACR052W




p.D378N 17 27 0.614
IV 403,968 C T 488.19 missense AGOS_
ADL164C
Malate dehydrogenase (AgMDH2) c.196G > A p.A66T 27 16 0.372
IV 644,214 A G 568.19 missense AGOS_
ADL032W
Aconitase (AgACO1) c.1367A >
G
p.D456G 10 16 0.615
V 1,328,
889
C A 922.19 missense AGOS_
AER374C
Subunit of the mitochondrial alpha-
ketoglutarate dehydrogenase (AgKGD1)
c.1837G > T p.D613Y 27 27 0.5
V 1,328,
948
G A 711.19 missense AGOS_
AER374C
Subunit of the mitochondrial alpha-
ketoglutarate dehydrogenase (AgKGD1)
c.1778C > T p.T593M 25 23 0.479
VI 810,404 G T 482.19 missense AGOS_
AFR207C
Subunit of succinate dehydrogenase
(AgSDH3)
c.200C > A p.S67Y 20 18 0.473
VI 1,103,
105
G A 636.19 missense AGOS_
AFR367W
Fumarate reductase (AgOSM1) c.622G > A p.A208T 21 19 0.475
VI 1,585,
840
G T 635.19 missense AGOS_
AFR629W
Aconitase (AgACO2) c.1894G > T p.D632Y 36 24 0.400
VII 1,652,
466
A G 970.19 missense AGOS_
AGR323C
E3-binding protein of pyruvate
dehydrogenase (AgPDX1) a
c.677 T > C p.L226P 16 28 0.636
VI 681,082 C T 624.19 missense AGOS_
AFR134C
Alpha subunit of succinyl-CoA ligase
(AgLSC1)
c.193G > A p.A65T 23 24 0.510
Mitochondria




c.224A > G p.D75G 20 19 0.487




c.683C > T p.T228M 25 18 0.419
IV 532,772 C A 1079.19 missense AGOS_
ADL087W
Cytochrome b reductase (AgCBR1)a c.155C > A p.T52N 25 34 0.576
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c.561G > T p.W187C 21 17 0.447
V 1,227,
029




c.190G > A p.A64T 11 15 0.577
VI 899,775 G A 668.19 missense AGOS_
AFR255W




p.G475S 27 22 0.449
VI 1,243,
899




c.943G > A p.V315M 16 26 0.619
VII 1,441,
269
C A 874.19 missense AGOS_
AGR196W
Glutathione-disulfide reductase (AgGLR1) a c.1415C > A p.S472Y 27 28 0.509
Riboflavin metabolism
II 194,781 G T 733.19 missense AGOS_
ABL109W
Riboflavin kinase (AgFMN1) c.80G > T p.S27I 20 22 0.524
IV 182,017 G A 687.19 missense AGOS_
ADL296C
GTP cyclohydrolase II (AgRIB1) c.230C > T p.P77L 23 23 0.500
Glycine, serine, threonine metabolism
I 448,391 G A 962.19 missense AGOS_
AAR059C
Threonine synthase (AgTHR4) c.685C > T p.R229W 19 29 0.604
III 125,457 G A 821.19 missense AGOS_
ACL130C
Phosphoserine phosphatase (AgSER2) c.140C > T p.A47V 28 27 0.491
III 727,688 C T 572.19 missense AGOS_
ACR215C
Serine hydroxymethyltransferase (AgSHM2) c.593G > A p.R198Q 24 20 0.455
VII 1,057,
290
T C 592.19 missense AGOS_
AGR012C
Cystathionine beta-synthase (AgCYS4) c.269A > G p.K90R 16 19 0.543
VII 1,446,
998
A G 720.19 missense AGOS_
AGR200W
Threonine aldolase (AgGLY1) c.1088A >
G
p.Y363C 14 20 0.588
Branched-chain amino acid metabolism
I 305,862 G A 960.19 missense AGOS_
AAL021W
Small subunit of acetohydroxyacid synthase
(AgILV6)
c.140G > A p.S47N 25 29 0.537
I 305,877 G A 923.19 missense AGOS_
AAL021W
Small subunit of acetohydroxyacid synthase
(AgILV6)
c.155G > A p.S52N 28 30 0.517
I 306,395 G T 711.19 missense AGOS_
AAL021W
Small subunit of acetohydroxyacid synthase
(AgILV6)
c.673G > T p.G225C 23 22 0.489
II 729,493 G A 1028.19 missense AGOS_
ABR174W
Branched-chain amino acid biosynthesis
activator (AgLEU3)
c.704G > A p.G235D 23 33 0.589
II 730,278 G A 915.19 missense AGOS_
ABR174W




p.A497T 22 26 0.542
VI 12,855 C A 543.19 missense AGOS_
AFL229W
2-isopropylmalate synthase (AgLEU4) c.1051C > A p.P351T 26 19 0.422
VII 1,381,
676
C T 564.19 missense AGOS_
AGR169W
3-isopropylmalate dehydratase (LEU1) c.226C > T p.H76Y 12 17 0.586
VII 1,382,
933
T C 745.19 missense AGOS_
AGR169W
3-isopropylmalate dehydratase (LEU1) c.1483 T >
C
p.S495P 26 25 0.490
Aromatic amino acid metabolism
II 206,627 C T 580.19 missense AGOS_
ABL102C
3-deoxy-D-arabino-heptulosonate-7-
phosphate (DAHP) synthase (AgARO3)
c.935G > A p.C312Y 28 18 0.391
II 799,743 C A 554.19 missense AGOS_
ABR209W
Anthranilate synthase (AgTRP2) c.982C > A p.L328I 15 16 0.516
VI 1,313,
765
T A 750.19 missense AGOS_
AFR485C
Tryptophan synthase (AgTRP5) c.1917A > T p.Q639H 33 29 0.468
VI 1,426,
745
G T 476.19 missense AGOS_
AFR548C
Aromatic aminotransferase I (AgARO8) c.544C > A p.P182T 29 16 0.356
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p.R1179H 22 21 0.488
VII 1,158,
247






p.G1308S 29 31 0.517
Sulfur amino acid metabolism
I 361,523 G A 834.19 missense AGOS_
AAR010W
Transcriptional activator of sulfur
metabolism (AgMET28)
c.719G > A p.R240Q 28 25 0.472
II 259,309 C T 578.19 missense AGOS_
ABL077W
Beta subunit of sulfite reductase (AgMET5)
a
c.3002C > T p.A1001V 25 19 0.432




c.499G > A p.G167S 25 23 0.479




c.1210G > T p.V404L 16 32 0.667
III 585,577 C A 547.19 missense AGOS_
ACR134W
Folylpolyglutamate synthetase (AgMET7) c.1135C > A p.L379M 25 17 0.405
IV 646,485 G A 838.19 missense AGOS_
ADL031W
O-acetyl homoserine-O-acetyl serine sulfhy-
drylase (AgMET17)
c.302G > A p.G101D 23 26 0.531
V 1,338,
633
G A 974.19 missense AGOS_
AER377C
Component of cytosolic iron-sulfur protein
assembly machinery (AgMET18)
c.1061C > T p.T354I 28 31 0.525
VI 1,699,
984
C A 936.19 missense AGOS_
AFR682C
L-homoserine-O-acetyltransferase (AgMET2) c.1045G > T p.A349S 20 32 0.615
VI 1,720,
007




c.731G > A p.G244D 30 13 0.302
VII 1,511,
391
C A 892.19 missense AGOS_
AGR237C
Alpha subunit of assimilatory sulfite
reductase (AgMET10)
c.2268G > T p.E756D 22 28 0.560
VII 1,512,
792
C A 606.19 missense AGOS_
AGR237C
Alpha subunit of assimilatory sulfite
reductase (AgMET10)
c.867G > T p.E289D 27 22 0.449
VII 1,685,
571
G A 715.19 missense AGOS_
AGR343W
Component of cytosolic iron-sulfur protein
assembly (CIA) machinery
c.563G > A p.R188H 24 21 0.467
Other amino acid metabolism
III 169,882 C T 367.19 missense AGOS_
ACL096W
Proline utilization transactivator (AgPUT3) c.382C > T p.R128W 26 14 0.350
IV 98,235 C A 727.19 missense AGOS_
ADL346W
Alpha-aminoadipate reductase (AgLYS2) c.1648C > A p.L550M 27 23 0.460
VI 1,397,
559
C A 864.19 missense AGOS_
AFR534W
Small subunit of carbamoyl phosphate
synthetase (AgCPA1)
c.976C > A p.P326T 29 25 0.463
VII 389,521 C A 724.19 missense AGOS_
AGL165W
Proline oxidase (AgPUT1) a c.104C > A p.T35K 28 24 0.462
VII 1,708,
538
T G 528.19 missense AGOS_
AGR357W
Asparaginase (AgASP1) c.311 T > G p.I104R 19 17 0.472
Purine, pyrimidine nulceotide metabolism




c.218C > T p.T73I 16 16 0.500




c.232G > T p.D78Y 29 22 0.431
II 784,947 G A 618.19 missense AGOS_
ABR204C
AMP deaminase (AgAMD1) c.1553C > T p.T518I 38 21 0.356




c.2067G > T p.R689S 21 25 0.543
III 214,069 A T 441.19 missense AGOS_
ACL077C
Ribose-5-phosphate isomerase (AgRKI1) c.17 T > A p.I6N 29 17 0.370




c.84 T > A p.N28K 26 24 0.480
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III 654,234 C T 690.19 missense AGOS_
ACR170C
Uridylate kinase (AgURA6) c.152G > A p.R51H 14 21 0.600




C.926C > A p.A309D 23 21 0.477







p.E759K 19 31 0.620







p.M689I 27 23 0.460
IV 580,072 G T 461.19 missense AGOS_
ADL057W
Large subunit of ribonucleotide reductase
(AgRNR1)
c.2520G > T p.K840N 16 15 0.483




c.488A > G p.Q163R 24 33 0.578
VI 896,312 A T 502.19 missense AGOS_
AFR254C
Aminoimidazole ribotide synthetase and
glycinamide ribotide synthetase (AgADE5,7)
c.1654 T >
A
p.L552I 20 15 0.428
VI 978,821 C A 584.19 missense AGOS_
AFR297W
Myb-related transcription factor (AgBAS1) c.905C > A p.P302H 23 20 0.465
VII 108,330 G A 674.19 missense AGOS_
AGL320C
CTP synthase (AgURA7) c.1361C > T p.T454I 23 25 0.521
VII 430,379 G A 703.19 missense AGOS_
AGL146W
GTP cyclohydrolase (AgURC1) c.1247G >
A
p.G416D 27 21 0.438
VII 1,072,
826




c.814A > G p.T272A 26 13 0.333
Fatty acid metabolism
I 564,702 G A 769.19 missense AGOS_
AAR124C
Carnitine acetyl-CoA transferase (AgCAT2) c.1736C > T p.S579F 19 23 0.548
IV 1,430,
996




c.1405C > T p.R469C 22 26 0.542
IV 1,436,
329




c.2170C > A p.L724I 35 28 0.444
IV 1,437,
793






c.706C > T p.Q236* 30 25 0.455
IV 1,443,
883
T A 729.19 nonsense AGOS_
ADR408W
Acetyl-coA synthetase (AgACS1) c.1128 T >
A
p.Tyr376* 21 23 0.523
V 794,683 T C 631.19 missense AGOS_
AER085C




p.K1946R 23 19 0.452
V 797,843 T G 419.19 missense AGOS_
AER085C
Beta subunit of fatty acid synthetase
(AgFAS1) a
c.2677A > C p.K893Q 38 15 0.283
V 797,858 C A 1299.19 missense AGOS_
AER085C
Beta subunit of fatty acid synthetase
(AgFAS1) a
c.2662G > T p.D888Y 14 38 0.731
VI 172,719 A T 746.19 missense AGOS_
AFL138W
Alpha subunit of fatty acid synthetase
(AgFAS2)
c.7A > T p.M3L 19 26 0.578
VI 175,856 C A 656.19 missense AGOS_
AFL138W
Alpha subunit of fatty acid synthetase
(AgFAS2)
c.3144C > A p.F1048L 21 21 0.500
VI 1,507,
650




c.832A > T p.L278M 21 22 0.512
VII 421,657 G T 728.19 missense AGOS_
AGL148C
Acetyl-coA synthetase (AgACS2) c.772C > A p.Q258K 24 24 0.500
VII 422,089 C T 804.19 missense AGOS_
AGL148C
Acetyl-coA synthetase (AgACS2) c.340G > A p.A114T 25 26 0.510




c.814C > A p.P272T 25 17 0.405
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mutations were also detected in genes involved in heme
biosynthesis and sulfur metabolism (Table 2).
We detected homozygous mutations in the AgSHM2,
AgARO2, AgILV2, and AgLYS5 genes involved in amino
acid biosynthesis (Table 1). Heterozygous mutations in
genes involved in amino acid metabolism were concen-
trated in glycine, serine, and threonine metabolism;
branched-chain amino acid biosynthesis; and aromatic
amino acid biosynthesis (Table 2). In our previous study,
the increased expression of AgTRP2 (ABR209W) and
AgTRP5 (AFR485C) was observed in MT strain by a prote-
omic analysis. AgTRP2 and AgTRP5 are annotated as
anthranilate synthase and tryptophan synthase, respectively,
which belong to the tryptophan biosynthetic pathway.
These results suggest that these amino acid metabolic path-
ways may be linked to riboflavin production in A. gossypii.
Several heterozygous mutations were detected in genes
involved in sulfur amino acid metabolism. In particular,
the sulfur amino acid biosynthesis pathway contains
heterozygously mutated genes in the MT strain {AgMET5
(AGOS_ABL077W), AgMET6 (AGOS_ABR212C),
AgSTR3 (AGOS_ACL059C), AgMET17 (AGOS_
ADL031W), AgMET2 (AGOS_AFR682C), AgSAM2
(AGOS_AFR692C), AgMET10 (AGOS_AGR237C)}.
Mainly, genes encoding all enzymes that catalyze homo-
cysteine in S. cerevisiae, except the adenosylhomocystei-
nase encoded by the AgSAH1 gene, were heterozygously
mutated. These results suggest that methionine metabol-
ism, which consists of one-carbon metabolism together
with folate metabolism, may be associated with riboflavin
production in A. gossypii. The AgMET10 and AgMET5
genes encode alpha and beta subunits of sulfite reductase
in S. cerevisiae, respectively, which are both flavoproteins.
It was previously reported that riboflavin production
in A. gossypii was improved by disruption of the
AgURA3 gene, which leads to blockage of the pyrimidine
biosynthetic pathway in this organism [33]. In the MT
strain, several genes in the pyrimidine biosynthetic path-
way have heterozygous mutations (Table 2). These re-
sults suggest that pyrimidine metabolism, including the
pyrimidine de novo and salvage pathways, may be asso-
ciated with riboflavin production in A. gossypii. In the
purine biosynthetic pathway, the AgRKI1 (AGOS_
ACL077C), AgRPS1 (AGOS_AER083C), AgADE5,7
(AGOS_AFR254C), AgADE8 (AGOS_AAR120C), and
AgADE2 (AGOS_ACR210C) genes have heterozygous
mutations in the MT strain. Moreover, the AgBAS1 gene


















I 380,486 A C 573.19 missense AGOS_
AAR021W
Protoporphyrinogen oxidase (AgHEM14) a c.617A > C p.E206A 30 21 0.412
II 203,080 T C 1002.19 missense AGOS_
ABL104C
5-aminolevulinate synthase (AgHEM1) c.1397A >
G
p.E466G 18 31 0.633
V 1,281,
270
T A 552.19 nonsense AGOS_
AER351W
Uroporphyrinogen-III synthase (AgHEM4) c.762 T > A p.Y254* 19 20 0.513
VII 1,608,
654




c.1412dupC p.A472fs 19 19 0.500
Other flavoprotein
III 660,436 G T 853.19 missense AGOS_
ACR175W
Sulfhydryl oxidase (AgERV2) a c.441G > T p.W147C 28 28 0.500
IV 94,090 G A 485.19 missense AGOS_
ADL348W




G A 658.19 missense AGOS_
AGR330W
Aminodeoxychorismate lyase (AgABZ2) c.208G > A p.V70M 29 23 0.442
VII 1,674,
504
C A 813.19 missense AGOS_
AGR335C
GTP-cyclohydrolase I (AgFOL2) c.343G > T p.D115Y 30 25 0.455
These heterozygous mutations are a subset among all 1382 heterozygous mutations which are shown in Table S2
aFlavoproteins
*Translation stops here
Table 3 Number of mutated genes encoding flavoproteins
Totala Homozygous Heterozygous Mutation rate
FAD-dependent 36 1 (1) 11 (9) 33.3%
FMN-dependent 16 1 (1) 2 (1) 18.8%
aTotal number of each flavoproteins is showed based on the reference by
Gudipati et al. [42]
Each bracket indicates the number of mutated genes encoding
mitochondrial proteins
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(AGOS_AFR297W), which encodes the transcription
factor for regulation of the purine and glycine biosyn-
thesis pathways in A. gossypii [45], also has one hetero-
zygous mutation. These heterozygous mutations may
partially force the restriction of purine biosynthesis,
which is important for riboflavin production in A. gossy-
pii. This limited purine biosynthesis in A. gossypii was
also reported by Ledesma-Amaro et al., who showed the
downregulation of purine biosynthesis during riboflavin
production [43].
In addition to mutations in genes involved in metabolic
pathways in A. gossypii, 17 heterozygous mutations in genes
involved in DNA repair were detected (Table 4). In particu-
lar, genes involved in mismatch DNA repair {AgMSH2
(AGOS_AAL093C), AgMSH3 (AGOS_ADR168C), AgMSH6
(AGOS_AGR116W), AgMLH1 (AGOS_AFL199C),
AgMLH2 (AGOS_AFR226C), AgMLH3 (AGOS_AAL093C),
and AgPMS1 (AGOS_AER421W)} were heterozygously mu-
tated. These proteins function cooperatively to repair DNA
mismatches in S. cerevisiae. Among MutS homologs, genes
encoding AgMSH2, AgMSH3 and AgMSH6 had heterozy-
gous mutations, but no mutation was detected in genes en-
coding AgMSH1, AgMSH4 and AgMSH5. ScMSH2,
ScMSH3 and ScMSH6 of S. cerevisiae function to maintain
nuclear genome stability [46]. In contrast, ScMSH1 func-
tions in mitochondria, and ScMSH4 and ScMSH5 function
during meiosis [47, 48]. These results suggest that the heter-
ologous mutations in AgMSH2, AgMSH3 and AgMSH6
may compromise the DNA mismatch repair pathway and
contribute to the maintenance of DNA mismatches and
















I 177,825 G T 533.19 missense AGOS_
AAL093C




p.L506M 22 17 0.436
IV 997,942 T G 729.19 missense AGOS_
ADR168C




p.K979N 39 23 0.371
IV 998,607 G A 982.19 nonsense AGOS_
ADR168C




p.Q758* 22 29 0.569
IV 1,446,
658
G T 747.19 missense AGOS_
ADR411W
Checkpoint protein (AgRAD17) c.358G > T p.D120Y 32 24 0.429
V 486,710 G A 711.19 missense AGOS_
AEL075W




p.A164T 18 22 0.550
V 1,239,
357




c.757G > T p.A253S 27 16 0.372
V 1,445,
972
G A 869.19 missense AGOS_
AER421W




p.A588T 23 28 0.549
VI 65,368 C T 587.19 missense AGOS_
AFL199C




p.C107Y 20 20 0.500






p.Q715* 25 30 0.545






p.D689Y 27 28 0.509






p.S807G 18 25 0.581






p.E1056* 29 22 0.431
VI 848,262 A G 828.19 missense AGOS_
AFR226C




p.F628L 26 31 0.544
VI 1,528,
970
C T 1142.19 nonsense AGOS_
AFR603C




p.W904* 18 36 0.667
VI 1,529,
553
G A 1151.19 missense AGOS_
AFR603C




p.P710S 12 33 0.733
VII 1,278,
725
T G 786.19 missense AGOS_
AGR116W




p.N335K 24 25 0.510
VII 1,368,
167
C T 788.19 missense AGOS_
AGR162C
DNA repair protein (AgRAD4) c.1214G >
A
p.R405Q 17 23 0.575
*Translation stops here
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accumulation of heterologous mutations in the genome of
A. gossypii during disparity mutagenesis and rapid evolution
of A. gossypii to the riboflavin-overproducing mutant MT
strain. Previous papers have shown that heterologous muta-
tions of the ScMSH2 gene showed mutator phenotypes in
diploid yeasts and suppression of the mismatch repair path-
way and proofreading-deficient DNA polymerase ε in hu-
man cells, leading to the accumulation of numerous
mutations [49, 50]. However, the riboflavin production level
in MT was stable during 14 passages [13].
As mentioned above, MT strain never produced its
haploid spores. Some heterozygous mutations were
found in genes involved in the sporulation (Table 5).
Two putative 1,3-β-D-glucan synthase genes (AGOS_
ACL181C, AGOS_AAR053W) had heterozygous muta-
tions. Especially, AGOS_AAR053W had one frameshift
mutation which may have great influences on the pro-
tein function. In S. cerevisiae, FKS2 is a 1,3-β-D-glucan
synthase during its sporulation and FKS2 and FKS3
works in spore wall assembly [51]. In addition, FKS2
binds to a sporulation-specific kinase, SMK1 [52]. Hetero-
zygous mutations of AGOS_ACL181C and AGOS_
AAR053W may have some influences on the sporulation in
MT strain. Moreover, we found heterozygous mutations in
AgIME2 (AGOS_AFR076W) and AgKAR4 (AGOS_
AFR736C) genes. Disruption of AgIME2 gene or AgKAR4
gene leads to the deficiency of its sporulation in A. gossypii
[53]. These heterozygous mutations may also be one of the
reasons for the sporulation deficiency in MT strain.
Gene Ontology (GO) enrichment analysis was per-
formed (Supplementary materials Tables S3, S4 and S5)
in the set of genes containing homozygous or heterozy-
gous mutations. Over-represented GO terms are ATP
binding, Protein binding and ATPase activity. Especially,
in “ATP binding”, all 22 ATP-dependent helicase genes
have a single heterologous mutation, respectively. It was
recently reported that RNA helicases have the relation-
ship with aging and life span of cells [54]. Mutations of
all RNA helicase genes support the suggestion that ribo-
flavin production in A. gossypii may be associated with
the aging of cells. Interestingly, we also found 25 mutated
genes among 139 genes in “oxidation-reduction process”
(Supplementary materials Table S3) and no mutated gene
was in “mitochondrion”. This result suggests that oxida-
tive stress is more associated with the riboflavin over-
production in MT strain than the mitochondrial dysfunc-
tion and supports the previous study showing a
riboflavin-overproducing A. gossypii mutant is vulnerable
to photoinduced oxidative DNA damage and accumulate
ROS [23], leading to the aging of cells. On the other
hand, “Ribosome”, “Translation”, “Structural constituent
of ribosome” and “Intracellular” were under-represented.
These GO terms contain ribosomal proteins involved in
translation (Supplementary materials Tables S5). Mutations
of genes encoding these proteins are lethal in organisms
and, therefore, these GO terms were under-presented.
Effect of temperature on riboflavin production in MT strain
By genomic analysis of the MT strain, one homozygous
mutation in the AgHSP104 gene (AGOS_AGL036C),
which causes a nonsense mutation, was detected (Table
1). This mutation generates the mutated AgHSP104,
composed of 355 amino acid residues at its N-terminus.
HSP104 in fungi contributes to the thermotolerance and
disaggregation of denatured and aggregated proteins,
ethanol tolerance and survival in the stationary phase
[55]. We confirmed this nonsense mutation in the MT
strain by DNA sequencing (Fig. 3a). In addition, other
four homozygous mutations in the MT strain were also
confirmed by DNA sequencing (Data not shown). These
results validate the results of the genomic analysis. The
WT and MT strains were cultivated on YD medium at
28 and 37 °C. The growth and riboflavin production in
WT cultivated at 37 °C were slightly lower than those in
WT cultivated at 28 °C (Fig. 3b). However, the growth of
and riboflavin production in the MT strain were dramat-
ically reduced at 37 °C compared to those at 30 °C, and
the MT strain was not able to grow normally. These re-
sults reflected the generation of truncated AgHSP104 in
the MT strain, leading to loss of thermotolerance, even
at 37 °C. This result also confirms the presence of the
homozygous mutation in the AgHSP104 gene of the MT
strain. Which corresponds, a homozygous missense mu-
tation was found in AgPMT1 gene (AGOS_ADR279C)
(Supplementary materials Table S1). This encodes a pu-
tative O-mannosyltransferase which is essential for the
cell wall integrity by O-glycosylation of cell wall manno-
proteins. In Aspergillus, the disruption of the genes
caused the high sensitivity of growth temperature and
low cell wall integrity [56, 57]. This mutation may also
partially contribute to the high sensitivity of growth
temperature in MT strain.
Effect of iron for the riboflavin production in MT strain
In Tables 2 and 3, many heterozygous mutations were
detected in genes encoding proteins involved in mito-
chondrial function and DNA. Iron-sulfur (Fe/S) clusters
are required for TCA cycles, the electron transfer chain
and fatty acid oxidation in mitochondria and DNA re-
pair in nucleus [58, 59]. Therefore, the addition of iron
ion for the MT strain cultivation was investigated. Fe3+
enhanced the growth of mycelia and riboflavin produc-
tion in the MT strain (Fig. 4a) also in the presence of
glycine, which is well-known for the improvement of the
riboflavin production in A. gossypii. Addition of Fe3+ and
Fe3+ + glycine improved the riboflavin production of
MT strain by 1.6 and 2.0 fold, respectively although we
were not able to find its significant differences. (Fig. 4b).
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c.4596A > C p.Lys1532Asn 23 37 0.617
II 101,053 T G 878.19 missense AGOS_
ABL159W
Component of the septin ring
(AgSHS1)
c.1229 T > G p.Ile410Ser 20 29 0.592
IV 649,360 G A 886.19 missense AGOS_
ADL029W
Component of the meiotic outer
plaque of the spindle pole body
(AgSPO74)
c.374G > A p.Ser125Asn 19 26 0.578









p.Gln507dup 21 28 0.571
IV 1,263,
702
G T 982.19 missense AGOS_
ADR317C
Dual-specificity kinase (AgMPS1) c.2228C > A p.Thr743Asn 24 31 0.564
VI 1,158,
992
A G 1022.19 missense AGOS_
AFR400C
N-formyltyrosine oxidase (AgDIT2) c.635 T > C p.Ile212Thr 25 32 0.561
III 48,243 C A 765.19 missense AGOS_
ACL179C
Meiosis-specific protein (AgSPO77) c.1601G > T p.Arg534Ile 18 23 0.561
VI 1,225,
184
A C 753.19 missense AGOS_
AFR436C
Component of the septin ring
(AgCDC11)
c.371 T > G p.Val124Gly 21 25 0.543
I 436,519 A AT 935.15 frameshift AGOS_
AAR053W
1,3-beta-D-glucan synthase
(AgGSC2 or AgFKS1 or AgFKS3)
c.916_
917insT
p.Arg306fs 24 28 0.538
VI 1,531,
918
T C 659.19 missense AGOS_
AFR604C
Component of the meiotic outer
plaque of the spindle pole body
(AgSPO21)
c.2531A > G p.Gln844Arg 18 20 0.526
VI 1,288,
694
G T 943.19 missense AGOS_
AFR469W
t-SNARE protein (AgSEC9) c.918G > T p.Glu306Asp 27 29 0.518
VI 672,483 C T 645.19 missense AGOS_
AFR130W
Protein involved in the control of
meiotic nuclear division (AgSSP1)
c.121C > T p.Leu41Phe 20 21 0.512
IV 1,456,
401
G T 500.19 missense AGOS_
ADR416W
Mitotic exit network scaffold
protein (AgNUD1)
c.1263G > T p.Gln421His 16 16 0.500
VI 639,702 C T 610.19 missense AGOS_
AFR111C
Component of the septin ring
(AgCDC3)
c.203G > A p.Gly68Asp 22 22 0.500
VII 1,087,
176




c.107G > A p.Ser36Asn 25 24 0.490
VI 1,225,
449
A T 596.19 missense AGOS_
AFR436C
Component of the septin ring
(AgCDC11)
c.106 T > A p.Ser36Thr 25 21 0.457
V 1,436,
486




c.4C > T p.Pro2Ser 21 17 0.447




c.1142A > C p.Tyr381Ser 30 24 0.444
IV 1,423,
888




c.278G > A p.Ser93Asn 24 19 0.442
IV 650,376 A T 523.19 missense AGOS_
ADL029W
Component of the meiotic outer
plaque of the spindle pole body
(AgSPO74)
c.1390A > T p.Ile464Phe 26 19 0.422
VII 394,750 G A 560.19 missense AGOS_
AGL162C
Sm-like protein (AgSEC1) c.1972C > T p.Pro658Ser 26 19 0.422
III 506,687 T G 578.19 missense AGOS_
ACR083C
Meiosis-specific component of the
spindle pole body (AgDON1 or
AgCUE5)
c.237A > C p.Arg79Ser 28 18 0.391




c.1161G > T p.Glu387Asp 40 21 0.344
VI 1,794,
575
A C 577.19 missense AGOS_
AFR736C
Transcription factor required for
response to pheromones
(AgKAR4)
c.422 T > G p.Phe141Cys 46 21 0.313
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Specific riboflavin production of MT strain in the pres-
ence of Fe3+ and Fe3+ + glycine were also improved by
1.4 and 1.3 fold, respectively although we were not able
to find its significant differences. These results indicate
that Fe3+ and glycine enhanced the riboflavin production
by the improvement of its growth. Flavoproteins in
mitochondria of yeasts function in redox processes via
the transfer of electrons [41]. In addition, the flavin in
flavoproteins participates in iron metabolism. We found
two homozygous mutations (AgARO2, AgILV2) and 13
heterozygous mutations (AgSDH1, AgPDX1, AgNDI1,
AgDLD1, AgCBR1, AgGLR1, AgMTO1, AgMET5,
AgPUT1, AgFAS1, AgHEM14, AgERV2, and AgERO1) in
genes encoding putative flavoproteins. Most of these fla-
voproteins may localized in mitochondria (Tables 1, 2
and 3). We previously reported that lactate and pyruvate
was produced more in MT strain than WT strain in the
minimum medium and succinate was decreased in MT
strain compared to WT stain [16]. In addition, gene ex-
pression of most of genes involved in TCA cycle was
down-regulated in MT strain cultivated compared to
WT stain [13]. In Fig. 4, the growth and riboflavin pro-
duction in MT strain were enhanced by the addition of
iron ion, which is involved in mitochondrial functions
with flavoproteins [41, 58, 59]. This result also supports
the relationship of riboflavin production with the mito-
chondrial dysfunction. The addition of Fe2+ had no ef-
fect on the riboflavin production in WT strain (Data not
shown).
Conclusion
In this study, we analyzed the genomic sequence of the
riboflavin-overproducing mutant MT strain and detected
some intriguing homozygous and heterozygous mutations
in the coding sequences of the MT genome. The
homozygous and heterozygous mutations were concen-
trated in genes encoding proteins involved in the TCA
cycle, mitochondrial functions, sulfur metabolism and
DNA mismatch repair. The discovery of many hetero-
zygous mutations indicates that mutants with many
heterozygous mutations cannot be isolated by conven-
tional mutagenesis methods, such as the use of muta-
gens and genetic engineering. Disparity mutagenesis is
a promising tool for the creation of new types of
eukaryotic mutants in various research fields and
manufacturing industries. Additionally, the genomic
analysis and GO enrichment analysis showed the rela-
tionship of the riboflavin production in MT strain with
oxidative stress and the aging of cells, supporting the
previous result that the accumulation of ROS and DNA




A. gossypii ATCC10895, which was purchased from
American Type Culture Collection (ATCC), was used as
a wild-type strain (WT strain). The A. gossypii w122032
mutant (MT strain) was previously isolated by disparity
mutagenesis in the presence of H2O2, itaconate and ox-
alate [13] and used as a mutant strain in this study.
These strains were maintained at 28 °C in YD medium
(1% yeast extract, 1% glucose, pH 6.8). Chemically de-
fined medium (15 g/L glucose as a carbon source, 1.5 g/
L asparagine, 0.75 g/L KH2PO4, 0.1 g/L myo-inositol, pH
6.8) was used as a minimal medium [16]. To cultivate A.
gossypii in flasks, mineral ions (4.4 mg/L CoCl2·6H2O,
18.0 mg/L MnCl2·4H2O, 44.0 mg/L ZnSO4·7H2O, 10.1
mg/L MgSO4·7H2O, 27.0 mg/L FeCl3·6H2O, 21.9 mg/L
CaCl2·6H2O, and 2.7 mg/L CuSO4·5H2O) were added to
Fig. 3 Growth and riboflavin production of MT strain. a Sequence of AgHSP104 gene in the MT strain. The gene sequence was confirmed by
Sanger method. b Growth of and riboflavin production in WT and MT on YD medium at 28 and 37 °C for 5 d
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the minimal medium. Cultivation was carried out using
a 500-ml flask (working volume 50ml) with an agitation
rate of 120 rpm at 28 °C. The chemically defined
medium was used for cultivation on agar plates. Each
amino acid was used to supplement the media at 1 mM.
Assay
The amount of riboflavin was determined according to a
previous protocol [16]. Briefly, 0.8 mL of the culture
broth was thoroughly mixed with 0.2 mL of 1 N NaOH.
A 0.4-mL aliquot of the resulting solution was neutral-
ized with 1 mL of 0.1 M potassium phosphate buffer
(pH 6.0), and the absorbance of the solution at a wave-
length of 444 nm was measured. The riboflavin concen-
tration was calculated with an extinction coefficient of
1.04 × 10− 2 M− 1 cm− 1 (127 mg riboflavin/L at ABS444).
Genome analysis
Genomic DNA was extracted from mycelia cultivated in
YD medium during the logarithmic phase using the
DNeasy Plant Mini Kit (Qiagen, Venlo, Netherlands)
and fragmented using a Covaris Acoustic Solubilizer
(Covaris, Woburn, MA, USA). Genomic libraries were
prepared using the TruSeq Nano DNA Library Prep Kit
(Illumina, San Diego, CA, USA) and sequenced using a
MiSeq system (Illumina) at the Instrumental Research
Support Office, Research Institute of Green Science and
Technology, Shizuoka University.
Paired-end reads (2 × 301 bp) were cleaned up using
Trimmomatic ver. 0.36 [60] by trimming adapter se-
quences, low-quality reads (quality score, < 15), and the
final 301 bases, followed by filtering reads less than
150 bp. High-quality reads were aligned to the refer-
ence genome of A. gossypii ATCC10895 using BWA-
MEM ver. 0.7.12 [61]. Aligned reads were sorted and
duplicates were marked using Picard Tools ver. 2.8.0
(http://broadinstitute.github.io/picard/). The Genome
Analysis Toolkit ver. 3.7 [62] was used to call variants,
SNPs and short insertions/deletions (indels). The vari-
ants identified by HaplotypeCaller in GATK were fil-
tered using Variant Filtration under the following
settings: QualByDepth (QD) < 6.0; RMSMappingQual-
ity (MQ) < 50; Quality (QUAL) < 100. Annotation of
each variant and its functional effect was predicted
using SnpEff ver. 4.3 T [63] with the default database of
“Ashbya_gossypii”. All proteins of A. gossypii were an-
notated using HMMER 3.1b2 (http://hmmer.org)
against Pfam database 32.0 [64]. GO terms associated
with Pfam entries were assigned using the pfam2go
mapping file (http://www.geneontology.org/external2
go/pfam2go, version date of 2019/06/01). Two-sided
Fisher’s exact test was performed to find the GO terms
over- and under-represented in the homozygously and
heterozygously mutated genes. The significance thresh-
old of over- and under-represented GO terms was de-
fined as a false discovery rate (FDR) of 0.05.
Fig. 4 Growth and riboflavin production in the WT and MT strains in the presence of Fe3+ and glycine. a Growth of WT and MT strains on the
minimum medium plate containing Fe3+ and glycine. Fe3+ and glycine were supplemented at 27 mg/L and 1mM, respectively. b Riboflavin
production of MT strain n minimal medium supplemented with 27mg/L Fe3+ and 1 mM glycine. The amount of riboflavin and dry cell was
measured at 4 days. Metal ions except for Fe3+ were not supplemented in both cultivations
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